These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1490588)

  • 1. Effects of atrial natriuretic peptide and toad heart extract on isolated toad Bufo arenarum aortic rings.
    Peral de Bruno M; Coviello A
    Gen Comp Endocrinol; 1992 Dec; 88(3):424-33. PubMed ID: 1490588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin converting enzyme inhibitor potentiated the vasorelaxant response of atrial natriuretic peptide in toad aortic rings.
    de Bruno MP; Coviello A
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 95(2):327-32. PubMed ID: 1977559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relaxation of non-contracted smooth muscle by atrial natriuretic peptide.
    Peral de Bruno M; Coviello A; Meyer M; Forssmann WG
    Clin Exp Hypertens A; 1992; 14(6):1125-39. PubMed ID: 1424220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of angiotensin II on isolated toad (Bufo arenarum) aortic rings.
    Peral de Bruno M; Lebenshon de Chialvo P; Coviello A
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(1):195-201. PubMed ID: 2904859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide relaxes arterial basal tone induced by coarctation hypertension.
    Peral de Bruno M; Romano L; Proto M; Coviello A
    Peptides; 1999; 20(4):485-91. PubMed ID: 10458519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of phosphorylase A formation and calcium content in aortic smooth muscle and smooth muscle cells: effects of atrial natriuretic peptide II.
    Cornwell TL; Lincoln TM
    J Pharmacol Exp Ther; 1988 Nov; 247(2):524-30. PubMed ID: 2846823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nitric oxide on the vasorelaxant effect of atrial natriuretic peptide on rabbit aorta basal tone.
    Romano L; Coviello A; Jerez S; Peral de Bruno M
    Can J Physiol Pharmacol; 2002 Oct; 80(10):1022-9. PubMed ID: 12450070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic factor inhibits angiotensin-, norepinephrine-, and potassium-induced vascular contractility.
    Kleinert HD; Maack T; Atlas SA; Januszewicz A; Sealey JE; Laragh JH
    Hypertension; 1984; 6(2 Pt 2):I143-7. PubMed ID: 6539299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin II antagonists on the contractile and hydrosmotic effect of AT II and AT III in the toad (Bufo arenarum).
    Peral de Bruno M; Coviello A
    J Comp Physiol B; 1996; 165(7):565-70. PubMed ID: 8617893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan reduces the vasorelaxant effect of atrial natriuretic peptide on basal tone in aorta.
    Peral de Bruno M; Romano L; Coviello A
    Clin Exp Hypertens; 1999 Nov; 21(8):1257-71. PubMed ID: 10574412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasorelaxant effects of and receptors for atrial natriuretic peptides in the mesenteric artery and aorta of the rat.
    St-Louis J; Schiffrin EL
    Can J Physiol Pharmacol; 1988 Jul; 66(7):951-6. PubMed ID: 2850846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive and vasorelaxant activities of Laelia autumnalis are mainly through calcium channel blockade.
    Vergara-Galicia J; Ortiz-Andrade R; Castillo-España P; Ibarra-Barajas M; Gallardo-Ortiz I; Villalobos-Molina R; Estrada-Soto S
    Vascul Pharmacol; 2008 Jul; 49(1):26-31. PubMed ID: 18534917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of atrial natriuretic peptide on cytosolic free calcium in cultured vascular smooth muscle cells.
    Takeuchi K; Abe K; Yasujima M; Sato M; Kanazawa M; Yoshinaga K
    Tohoku J Exp Med; 1989 May; 158(1):47-56. PubMed ID: 2476868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic atrial peptide inhibits intracellular calcium release in smooth muscle.
    Meisheri KD; Taylor CJ; Saneii H
    Am J Physiol; 1986 Jan; 250(1 Pt 1):C171-4. PubMed ID: 2934990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects of a synthetic atrial peptide on contractions and 45Ca fluxes in vascular smooth muscle.
    Taylor CJ; Meisheri KD
    J Pharmacol Exp Ther; 1986 Jun; 237(3):803-8. PubMed ID: 2423684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of K+ channels in the relaxant effect of vasoactive intestinal peptide and atrial natriuretic peptide in isolated guinea-pig trachea.
    Thirstrup S; Nielsen-Kudsk JE; Mellemkjaer S
    Eur J Pharmacol; 1997 Jan; 319(2-3):253-9. PubMed ID: 9042598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of high calcium diet on arterial smooth muscle function and electrolyte balance in mineralocorticoid-salt hypertensive rats.
    Arvola P; Ruskoaho H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):948-58. PubMed ID: 8485634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxation and modulation of cyclic AMP production in response to atrial natriuretic peptides in guinea pig tracheal smooth muscle.
    Devillier P; Corompt E; Bréant D; Caron F; Bessard G
    Eur J Pharmacol; 2001 Nov; 430(2-3):325-33. PubMed ID: 11711051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible mechanisms of age-associated reduction of vascular relaxation caused by atrial natriuretic peptide.
    Moritoki H; Yoshikawa T; Hisayama T; Takeuchi S
    Eur J Pharmacol; 1992 Jan; 210(1):61-8. PubMed ID: 1350988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.